Since 1935 several reports have dealt with the antistreptolysin-O (ASO) titre in rheumatoid arthritis (RA). The mean and the upper ASO values were first established in a group of normal subjects and in patients with no history of recent streptococcal illness, and subsequently the distribution of the ASO titres was recorded in patients suffering from RA. Table I summarizes the results of Blair and Hallman (1935) , Dawson and Olmstead (1936) , Longcope (1936) , Goldie and Griffiths (1936) , Bunim and McEwen (1940) , Winblad (1941) , Westergren and Stavenow (1947) , van Loghem-Langereis (1950) , Oker-Blom and Widholm (1952) , Quinn and Liao (1952) , Jacqueline, Eyquem, and Jochem (1954) , Otten and Westendorp Boerma (1959) . These results are very divergent; most studies show higher ASO titres in patients with RA, but the significance * Present address: Bruineveld, 15, Belgium. of this difference is variable. Moreover, in most of the reported studies, the control group was not matched to the patient group with regard to age distribution; the controls were often physicians or laboratory-workers and were investigated at different seasons of the year. All these factors might influence the ASO titres. Furthermore, no data were available about the epidemiology of 3-haemolytic streptococci in RA, nor about the antibody response of such patients in long-term studies. The behaviour of RA patients in the case of a common bacterial infection is a worth-while study, since in recent years much stress has been laid on possible immunological disturbance in rheumatoid disease, and since experimental and clinical evidence favours the hypothesis that bacterial infection may be responsible for the origin of the rheumatoid factor (Eyquem, Guyot Jeannin, and Podliachouk, 1959; Abruzzo and Christian, 1961; Svartz, 1962; Williams and All RA patients suffered from definite rheumatoid arthritis according to the criteria of the American Rheumatism Association (Ropes, Bennett, Cobb, Jacox, and Jessar, 1959) . Activity of the disease was not taken into account. Half of the patients were treated with gold, the other half received acetylsalicylic acid, antimalarial drugs, pyramidon, or phenylbutazone. Only two patients received a short course of prednisone because of gold dermatitis. Eleven of these patients had to be hospitalized in the course of the study.
In the control group, cervical syndrome or disk lesion was diagnosed in thirteen cases, painful shoulder in eleven, osteo-arthritis in ten, lumbar disk lesion in nine, myalgia in seven, and "tennis elbow" in two; there were three miscellaneous cases and five with no abnormality. Three of these patients were hospitalized during the study.
Completion Rate.-63 RA patients and sixty NRA patients fulfilled the criteria and were followed for 6 months, the completion rate being 95 (Table II) .
Plan of the Study
Once a month each patient was asked about possible symptoms of streptococcal illness. A nose swab was introduced into each nostril; for the throat, we used two cotton wool swabs mounted on one cork stopper; both tonsils were swabbed with such a double throat swab; in the beginning of the study, before being swabbed, the tonsils of the patients were expressed with a wooden tongue spatula; later on, only swollen tonsils were first expressed.
A blood sample was drawn for determination of the ASO titre. The first blood sample was also used for the determination of the rheumatoid factor, antinuclear factors, total serum protein, and serum protein electrophoresis.
Once during the study, x-rays were taken of the sinuses in order to avoid a bias due to a greater incidence of infection foci of possible streptococcal origin in one group or the other.
Laboratory Methods
Swabs. Prevalence.-This signifies the number of subjects presenting a positive culture for 3-haemolytic streptococci at a certain time (point prevalence) or during a certain period (period prevalence); whether the recovered streptococcus had been acquired before or during the study is not taken into account.
From March to June (period-prevalence), rhaemolytic streptococci were found in thirty of the 54 RA patients and in 21 of the 55 NRA patients (Table III) . This difference has no statistical significance. Group A streptococci were recovered in eight RA patients and two NRA patients; this four-fold difference in prevalence does not reach a 5 per cent. significance level because of the small numbers involved and the necessity to apply Yates' correction for calculation. When Groups A, C, and G streptococci are combined-they are all known for their pathogenicity and their ability to produce streptolysin-O (Todd, 1939) -the difference between 23 RA patients and nine NRA patients is significant at the 1 per cent. level.
There was no great monthly variation in point prevalence (Table IV) . For Groups A, C, and G streptococci there was some tendency to increase from March to June, for Groups B, D, E, F, and H streptococci, some tendency to decrease.
The statistically significant difference between RA The monthly variations in the acquisition rate are shown in Fig. 1 (opposite) between the RA and NRA subjects (X(4) = 8X312; 0 10> P >0 05). However, a titre above 300 U ANNALS OF THE RHEUMATIC DISEASES was observed in only one NRA patient as opposed to nine RA patients; this difference in the distribution of titres above 300 U is statistically significant (X(1, = 7 209; 0-01 > P >0-005).
The distribution of the ASO titres is not the same for each month separately. In March and in April there is no significant difference at the 5 per cent. level for the distribution of all titres or for that of the higher titres (>300 U).
On the contrary, in May and June, the two groups differ statistically from each other, both for all titres (0 02> P >0 01) and for the higher titres, which are more frequent in the RA group. Titres of 300 U and even of 200 U can now be included among the higher values. The time factor is illustrated in Fig. 2 , in which the proportion of patients with an ASO value above 150 or 200 U is plotted against time. These percentages are greater in the RA group than in the NRA group. In the RA group they show only a slight decline from March to June, but in the control group there is a sharp decline from the beginning to the end of the study: the seasonal influence is thus more marked in the controls than in the RA patients. Zanen and others (1959) and James and others (1960) we may deduce that, in healthy adults of comparable age, 33 per cent. of Group A streptococcus acquisitions last for more than 4 months. In the RA patients of the present study, 45 per cent. of acquisitions lasted for more than 4 months and this figure might have been even greater if the follow-up period had been as long as that of the other studies.
What is the significance of the reduced ability of RA patients to eliminate pathogenic streptococci? There are three possible explanations:
(a) The reduced elimination of 3-haemolytic streptococci is the consequence of the chronic disease which lowers the resistance to all kinds of invading agents.
(b) f-haemolytic streptococci are one of the aetiological factors of rheumatoid disease or at least of the rheumatoid factor. (c) Both facts are the result of some immunological disturbance.
In the first hypothesis, a higher acquisition rate of P-haemolytic streptococci might also be expected, at least when the disease is active. In this study more acquisitions were observed in the RA group, but
